跳至主要内容
临床试验/EUCTR2004-001552-37-GB
EUCTR2004-001552-37-GB进行中(未招募)1 期

Effectiveness and Cost-effectiveness of Levonorgestrel containing Intrauterine system in Primary care against Standard Treatment for menorrhagia - ECLIPSE

niversity of Birmingham0 个研究点目标入组 570 人开始时间: 2005年2月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
570

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women between the ages of 25-50 presenting to General Practitioners with menorrhagia (see Section 3.2 of protocol for specific definition).
  • Not intending to become pregnant in the next 5 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 570
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Women taking HRT
  • Women with contraindications to IUD use, with or without Levonorgestrel
  • Women with contraindications to all medical treatments for menorrhagia
  • Women with abdominally palpable enlarged fibroid uteri (10-12 weeks size)
  • Women to whom the contraceptive effect of LNG-IUS would be unacceptable
  • Women with symptoms suggestive of other pathology:
  • Women with risk factors for endometrial cancer:

研究者

相似试验